Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater®) in the initial phase of chemotherapy in three 6- month regimens for smear-positive pulmonary tuberculosis: A five-year follow- up report

International Journal of Tuberculosis and Lung Disease

Volumn 3, Issue 2, 1999, Pages 126-132

  Teo, S K ^a,b  

^a ALEXANDRA HOSPITAL   (Singapore)

^b NONE   (Singapore)

Author keywords

Combined formulations; Fixed dose combinations; Rifater ; Short course chemotherapy

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; RIFATER; STREPTOMYCIN;

ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SINGAPORE; SPUTUM CULTURE; TREATMENT OUTCOME;

ANTITUBERCULAR AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FOLLOW-UP STUDIES; HUMANS; ISONIAZID; PYRAZINAMIDE; RECURRENCE; RIFAMPIN; STREPTOMYCIN; TUBERCULOSIS, PULMONARY;

EID: 0032997128     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Singapore Tuberculosis Service/British Medical Research Council. Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Am Rev Respir Dis 1988; 137: 1147-1150.
2. Singapore Tuberculosis Service/British Medical Research Council. Assessment of a daily combined preparation of isoniazid, rifampicin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Am Rev Respir Dis 1991; 143: 707-712.
3. Singapore Tuberculosis Service/British Medical Research Council. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Am Rev Respir Dis 1979: 579-585.
4. Singapore Tuberculosis Service/British Medical Research Council. Clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Am Rev Respir Dis 1985; 132: 374-378.
5. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council. A controlled clinical comparison of 6 and 8 months of antituherculosis chemotherapy in the treatment of patients with silicotuberculosis in Hong Kong. Am Rev Respir Dis 1991; 143: 262-267.
6. Ellard G A, Ellard D R, Allen B W, et al. The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined preparations designed for use in short-course treatment of tuberculosis. Am Rev Respir Dis 1986; 133: 1076-1080.
7. Comunicable Disease Centre. Communicable disease surveillance report 1996. Singapore: Department of Clinical Epidemiology, Communicable Disease Centre, Tan Tock Seng Hospital, 1996.
8. Edsall J, Collins J G, Gray J A C. The reactivation of tuberculosis in New York City in 1967. Amer Rev Respir Dis 1970; 102:725-735.
9. Chaulet P, Boulahbal F. Essai clinique d'une combinaison en proportions fixes de trois medicaments dans le traitement de la tuberculose. Tubercle Lung Dis 1995; 76: 407-412.
10. Punnotok J, Pumprueg U, Chakorn T. A comparison of two short course tuberculosis chemotherapy regimens, both using Rifater during an intensive phase, with a 3 year follow up. J Med Assoc Thai 1995; 78: 298-304.
11. Combs D L, O'Brien R J, Geiter L J. USPHS tuberculosis short-course chemotherapy trial 21: effectiveness, toxicity, and acceptability: the report of final results. Ann Intern Med 1990; 112: 397-406.
12. Hong Kong Chest Service/British Medical Research Council. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear positive pulmonary tuberculosis, including as assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Am Rev Respir Dis 1991; 143: 700-706.
13. International Union Against Tuberculosis and Lung Disease. Antituberculosis regimens of chemotherapy. Recommendations from the Committee on Treatment of the IUATLD. Bull Int Union Tuberc Lung Dis 1988; 63: 60-64.
14. World Health Organization Tuberculosis Program. Treatment of tuberculosis: guidelines for national programmes. (WHO/ TB/97/220) Geneva: World Health Organization, 1997.
15. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994; 149: 1359-1374.